Completion of the combination between Novozymes and Chr. Hansen

January 29, 2024 – Company announcement no. 2

Please see attachment.

CONTACT INFORMATION

Investor Relations
Tobias Cornelius Bjorklund
+45 3077 8682
tobb@novozymes.com

Anders Enevoldsen
+45 5350 1453
adev@novozymes.com

Press Relations
Lina Danstrup
+45 3077 0552
lind@novozymes.com

Attachment

• No. 2 Completion of the combination between Novozymes and Chr. Hansen